Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: ciprofloxacin / demerol / sulfa (sulfonamides) / nitroglycerin / morphine / clindamycin / benzonatate attending: chief complaint: shortness of breath in setting of tbm and silicone y stent major surgical or invasive procedure: flexible bronchoscopy history of present illness: 64f with history of tracheobronchomalacia s/p y stent placement on . today, presented to er with sob and difficulty clearing secretions. bronched there and with therapeutic aspiration. was transferred here for therapeutic aspiration and probably stent removal. past medical history: tracheobronchomalacia s/p y stent placement, gerd, copd, osa, cad, atrial fibrillation, fibromyalgia social history: + smoking 50 yr history married, lives w/husband family history: noncontributory physical exam: physical exam: temp (f): 98.2 heart rate: 102 blood pressure: 115/83 resp rate: 19 o2 sat(%): 97% ra heent; unremarkable chest: cta bilat cor: rrr s1, s2 extrem: no edema brief hospital course: pt was admitted from to the sicu on for close pulmonary monitoring while wawiting bronch to eval status of tracheal silicone y stent. placed on mucolytics and augmentin. a flexible bronchoscopy was done on and copious amounts of secretions were aspirated. stent was in correct position and subsequently free of secretions. pt remained stable and was transfered out of the icu w/ sats 97-98% on roomair. d/c to home on mucolytic regimen and augmentin for 7 days. will return on for y stent removal. medications on admission: lipitor 10', singulair 10', advar 2puffs'', spiriva 1', lorazepam 1', omeprazole 20', mucinex 1200'', augmentin, amitriptyline 50', albuterol discharge medications: 1. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 2. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 3. docusate sodium 50 mg/5 ml liquid sig: one (1) po bid (2 times a day). 4. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 5. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 6. tiotropium bromide 18 mcg capsule, w/inhalation device sig: one (1) cap inhalation daily (daily). 7. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). 8. ativan 1 mg tablet sig: one (1) tablet po once a day. 9. amitriptyline 50 mg tablet sig: one (1) tablet po hs (at bedtime). 10. guaifenesin 600 mg tablet sustained release sig: two (2) tablet sustained release po bid (2 times a day). disp:*120 tablet sustained release(s)* refills:*2* 11. amoxicillin-pot clavulanate 500-125 mg tablet sig: one (1) tablet po q8h (every 8 hours) for 7 days. disp:*21 tablet(s)* refills:*0* 12. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) inhalation q6h (every 6 hours). 13. fexofenadine 60 mg tablet sig: one (1) tablet po bid (2 times a day). 14. guaifenesin 100 mg/5 ml syrup sig: 5-10 mls po q6h (every 6 hours). 15. normal saline normal saline nebs q 4-6hrs discharge disposition: home discharge diagnosis: copd, tracheobronchomalacia s/p y stent placement discharge condition: good discharge instructions: call dr. office if you develop chest pain, shortness of breath, fever, chills, or nay symptoms that concern you. followup instructions: you are scheduled to have your stent removed on md procedure: fiber-optic bronchoscopy other intubation of respiratory tract diagnoses: obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery esophageal reflux atrial fibrillation personal history of tobacco use other postprocedural status chronic obstructive asthma with (acute) exacerbation myalgia and myositis, unspecified other diseases of trachea and bronchus 

Answer: The patient is high likely exposed to